Our meta-analysis combining seven clinical studies showed that LOX expression was associated with lymph node metastasis and tumor metastasis of GC patients but not correlated with gender, tumor differentiation, Lauren classification, and tumor depth of invasion. Here, LOX is linked to gastric cancer.